Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and Safety of Saroglitazar in Patients With Metabolic Disease in India Stratified by Estimated Glomerular Filtration Rate (eGFR): A Retrospective, Observational, Electronic Medical Record (EMR)-Based Real-World Evidence Study.

Cureus·2026
Same author

The Prediabetes Wake-Up Call: Time for Proactive Endocrine Care.

Indian journal of endocrinology and metabolism·2025
Same author

Prevention and Treatment of Vitamin D Deficiency in India: An Expert Group Consensus.

Indian journal of endocrinology and metabolism·2025
Same author

Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration.

Nature communications·2025
Same author

Best practices in the laboratory diagnosis, prognostication, prediction, and monitoring of Graves' disease: role of TRAbs.

BMC endocrine disorders·2024
Same author

Dry Eye in Diabetes: The Indian Diabetic and Endocrine Eye Diseases (INDEED) Review.

TouchREVIEWS in endocrinology·2024

Related Experiment Video

Updated: May 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Low density Lipoprotein cholesterol target: Changing goal posts.

Ganapathi Bantwal1, Belinda George

  • 1Department of Endocrinology, St. Johns Medical College Hospital, Bangalore - 560 034, Karnataka, India.

Indian Journal of Endocrinology and Metabolism
|April 9, 2013
PubMed
Summary

Aggressively lowering low density lipoprotein cholesterol (LDL) reduces cardiovascular events in diabetic patients. This review examines current trends in intensive LDL cholesterol reduction strategies for better heart health.

Keywords:
LDLcardiovascular diseasediabetes

Related Experiment Videos

Last Updated: May 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • Diabetology
  • Pharmacology

Background:

  • Elevated low density lipoprotein cholesterol (LDL) is a major modifiable risk factor for cardiovascular disease (CVD) in individuals with diabetes.
  • Pharmacological LDL lowering significantly reduces cardiovascular events in both primary and secondary prevention settings.
  • Diabetes management increasingly focuses on comprehensive cardiovascular risk reduction.

Purpose of the Study:

  • To review the current evidence and evolving trends in aggressive LDL cholesterol lowering strategies.
  • To discuss the benefits and considerations of intensive lipid management in diabetic patients.
  • To highlight the importance of targeting LDL cholesterol for cardiovascular event prevention.

Main Methods:

  • Literature review of clinical trials and observational studies.
  • Analysis of current guidelines and expert consensus statements.
  • Synthesis of data on pharmacological interventions for LDL reduction.

Main Results:

  • Consistent evidence supports the benefit of LDL lowering in reducing major adverse cardiovascular events (MACE).
  • Aggressive LDL reduction targets are increasingly recommended, particularly in high-risk populations like diabetic patients.
  • Novel therapeutic agents are expanding options for achieving lower LDL levels.

Conclusions:

  • Intensified LDL cholesterol lowering is a cornerstone of cardiovascular risk management in patients with diabetes.
  • The trend towards more aggressive lipid-lowering strategies is supported by robust clinical data.
  • Personalized treatment approaches are essential to optimize LDL reduction and minimize cardiovascular risk.